| Description |
1 online resource (241 pages) |
| Series |
Biopolitics |
|
Biopolitics--the bio-environment.
|
| Contents |
Introduction : the odyssey of Depo-Provera -- The Grady Hospital study : the corruption of contraceptive research -- The twenty-five-year FDA approval controversy : cancer and the politics of acceptable risk -- Contraceptive chaos : unapproved use and Upjohn v. MacMurdo -- Marketing approval and litigation : osteoporosis and the realities of medical risk -- Chemical castration : the John Hopkins Clinic and People v. Gauntlett -- Conclusion : contraceptive drug risk failure, human dignity, and a duty to act |
| Summary |
The story of Depo-Provera joins the national struggle over the drug's FDA approval to the state legal issues raised by its contraceptive and criminal justice uses.Depo-Provera is known as an injectable hormonal birth control method, but few are familiar with its dark and complicated history. Depo-Provera was tested on women since the mid-1960s without their informed consent until it was FDA-approved in 1992, but never FDA-approved as chemical castration for male sex offenders.Contraceptive Risk is William Green's landmark study of Depo-Provera. Based on a fascinating combination of archival materials and interviews, the book is framed as three interconnected stories told by Judith Weisz, who chaired the FDA's Public Board of Inquiry on Depo-Provera, a scientific court; by Anne MacMurdo who brought a products liability suit against Upjohn, the drug's manufacturer, for the deleterious side effects she suffered from the drug's use; and by Roger Gauntlett, an Upjohn heir who, when he was convicted of sexual assault, refused to take a dose of his family's own medicine as a probation condition. Together these three stories of Depo-Provera's convoluted fifty year odyssey call for a paradigm shift in pharmaceutical drug development.Contraceptive Risk is a thoroughly researched and engrossing approach to the scientific, political and institutional forces involved in health law and policy, as well as the multifaceted politics of measuring risk |
| Notes |
Print version record |
| Subject |
Medroxyprogesterone -- United States
|
|
Contraceptive drugs, Injectable -- United States -- Safety measures
|
|
Women -- Health risk assessment -- United States
|
|
POLITICAL SCIENCE -- Public Policy -- General.
|
|
Medroxyprogesterone
|
|
Women -- Health risk assessment
|
|
United States
|
| Form |
Electronic book
|
| ISBN |
9781479825929 |
|
1479825921 |
|
